Therapeutics: Prostate-specific membrane antigen (PSMA; FOLH1; GCPII); topoisomerase I (TOP1)

Cell culture and mouse studies suggest a dual PSMA-TOP1 binding conjugate could treat cancer without the toxicity of unconjugated TOP1 inhibitors. Chemical synthesis and testing in a human prostate ca...